These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 22098404
1. Very poor outcome of leukemic transformation in myelofibrosis: a single center experience with 13 patients. Helbig G, Wieczorkiewicz-Kabut A, Pajak J, Wieclawek A, Stachowicz M, Soja A, Rusek A, Karolczyk A, Bartkowska-Chrobok A, Kyrcz-Krzemien S. Leuk Lymphoma; 2012 Jun; 53(6):1236-8. PubMed ID: 22098404 [No Abstract] [Full Text] [Related]
2. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S, Van Dyke D, Hanson C, Wu W, Pardanani A, Cervantes F, Passamonti F, Tefferi A. J Clin Oncol; 2011 Feb 01; 29(4):392-7. PubMed ID: 21149668 [Abstract] [Full Text] [Related]
3. Effect of Red Blood Cell Transfusion Dependence on the Natural History of Myeloproliferative Neoplasm-Associated Myelofibrosis. Bartoszko J, Panzarella T, Lau A, Schimmer A, Schuh A, Shanavas M, Yee K, Gupta V. Clin Lymphoma Myeloma Leuk; 2015 Nov 01; 15(11):e151-6. PubMed ID: 26566925 [Abstract] [Full Text] [Related]
4. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study. Shrestha R, Giri S, Armitage JO, Bhatt VR. Future Oncol; 2017 Jun 01; 13(14):1239-1246. PubMed ID: 28589759 [Abstract] [Full Text] [Related]
12. Mutations and prognosis in primary myelofibrosis. Vannucchi AM, Lasho TL, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling RP, Rotunno G, Knudson RA, Susini MC, Laborde RR, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross NC, Tefferi A. Leukemia; 2013 Sep 01; 27(9):1861-9. PubMed ID: 23619563 [Abstract] [Full Text] [Related]
13. Leukemia risk models in primary myelofibrosis: an International Working Group study. Tefferi A, Pardanani A, Gangat N, Begna KH, Hanson CA, Van Dyke DL, Caramazza D, Vannucchi AM, Morra E, Cazzola M, Pereira A, Cervantes F, Passamonti F. Leukemia; 2012 Jun 01; 26(6):1439-41. PubMed ID: 22289985 [No Abstract] [Full Text] [Related]
18. Evaluation of survival risk scores in primary myelofibrosis: a Brazilian experience from a single institution. Linardi Cda C, Dalessandro T, Pracchia LF, Buccheri V. Leuk Lymphoma; 2008 Aug 01; 49(8):1641-3. PubMed ID: 18766976 [No Abstract] [Full Text] [Related]